Physician

Christopher T Kroodsma, M.D.

According to 2025 Medicare claims, Christopher Kroodsma, M.D. (NPI: 1336230051) practices dermatology in the Peoria, IL market, with the plurality of this provider's patient population coming from Peoria, IL. This provider's primary affiliated billing organization is CENTRAL ILLINOIS DERMATOLOGY, S.C. (NPI: 1548358054; TIN: 371086127) and primary practice location at 61614-5068.

Kroodsma's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,371 traditional Medicare patients, billed 7,586 HCPCS/CPT codes, and received $307,735 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,213 prescription claims across 483 beneficiaries totaling $379,771 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 10 records totaling $216. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $214,154 to $379,771. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,602	7,413	$284,478
2016	1,631	7,225	$254,954
2017	1,803	7,937	$276,874
2018	1,999	8,712	$295,478
2019	1,966	9,207	$321,567
2020	1,626	8,699	$282,190
2021	1,903	10,027	$364,595
2022	1,468	8,403	$292,710
2023	1,382	7,272	$293,304
2024	1,371	7,586	$307,735

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	466	1,221	$214,154
2016	494	1,249	$172,383
2017	596	1,423	$242,774
2018	684	1,780	$288,102
2019	687	1,764	$405,469
2020	577	1,584	$313,951
2021	645	1,583	$218,369
2022	532	1,365	$275,228
2023	479	1,204	$439,018
2024	483	1,213	$379,771

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	401	481	$65
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,159	1,775	$53
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	267	329	$33
17000	Destruction of precancer skin growth, 1 growth	1,093	1,622	$30
17003	Destruction of precancer skin growth, 2-14 growths	545	1,855	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Pen	Dupilumab	45	1,232	$168,840
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	331	7,718	$12,488
Betamethasone Dipropionate	Betamethasone Dipropionate	112	3,249	$3,290
Griseofulvin	Griseofulvin, Microsize	16	510	$2,766
Doxycycline Hyclate	Doxycycline Hyclate	131	5,367	$2,549

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$216	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher T. Kroodsma, M.D.?

Tedicare shows public-source Medicare data for Christopher T. Kroodsma, M.D. (NPI 1336230051), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher T. Kroodsma, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christopher T. Kroodsma, M.D.?

Christopher T. Kroodsma, M.D. is linked to CENTRAL ILLINOIS DERMATOLOGY, S.C. (billing NPI 1548358054) in the available physician profile data.

Does Christopher T. Kroodsma, M.D. have Open Payments data?

Christopher T. Kroodsma, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.